Total Funding
81
Total FundingSeries B raised
Growth Score
pts
Heat Score
29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
297223
Oculex Pharmaceuticals, Inc. operates as a drug delivery and pharmaceutical company.
About the Company
Oculex Pharmaceuticals is an ophthalmic drug delivery company that is focused on the development of therapeutic products for the treatment of sight-threatening diseases.
Oculex Pharmaceuticals develops Posurdex, a biodegradable release implant that delivers dexamethasone to the targeted disease site at the back of the eye.
Oculex Pharmaceuticals
was acquired by Allergan in November 2003.
Oculex Pharmaceuticals was founded in 1989 and is based in Sunnyvale, California.
